7
May
2024

Hangzhou Tomson Biopharma Co., Ltd.

Exhibitor at CPHI North America 2024 stand 446
About Us

HANGZHOU TOMSON BIOPHARMA CO., LTD.,a Chinese-based & worldwide operating company, which specializes in marketing, manufacture and R&D of Intermediate, API and Formulation, has professional and extensive networks in Europe, North & South America and Asia.

Our manufacturing and R&D base is located in Zhejiang, owing GMP approved synthesis & fermentation workshops and pilot workshops, which is ideal for cooperative development, technology transfer and industrialization.

Standing out for our advantaged and long-term presence in China, we are keeping well contact with hundreds of Chinese pharmaceutical companies, representative for many API & Formulation manufacturers and exclusively marketing their products.

We sincerely look forward to being your reliable and long-lasting partner, offering you our unique service as well as high-quality products.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2018
    On CPHI since
  • 3
    Certificates
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Generic APIs producer
Pharmaceutical Company (generic finished products)
Supply Chain
View company profile
Contact info
  • +86 571 89986272
  • Website
  • Building 8, Rising Center, No.369, Qingchuan Street,, Xihu District,, 310030, Hangzhou,, Zhejiang,, China
Show contact info Hide contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 446

Products Featured at CPHI North America 2024

  • Apalutamide

    Product Apalutamide

    Prostatic Neoplasms
  • Aprotinin

    Product Aprotinin

    EU approved.
  • Atogepant

    Product Atogepant

    Atogepant, is a medication used to prevent migraines. It is a gepant, an orally active calcitonin gene-related peptide receptor antagonist. 
  • Caspofungin Acetate

    Product Caspofungin Acetate

    A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES.
  • Dydrogesterone

    Product Dydrogesterone

    Generic APIs. 
  • Everolimus

    Product Everolimus

    USFDA EIR 
  • Isavuconazole / Isavuconazonium Sulfate

    Product Isavuconazole / Isavuconazonium Sulfate

    DMF ready. 
  • Liraglutide

    Product Liraglutide

    First Generic player in China. 
  • Micafungin

    Product Micafungin

    Micafungin is a cyclic hexapeptide echinocandin antibiotic which exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall. It is used as the sodium salt for the treatment of invasive candidiasis, and of aspergillosis in patients who are int...
  • Posaconazole

    Product Posaconazole

    EU WC, ASMF
  • Rimegepant

    Product Rimegepant

    Generic APIs. 
  • Semaglutide

    Product Semaglutide

    FDA EIR letter available for Manufacturing site
  • Sirolimus

    Product Sirolimus

    Graft Rejection ; Kidney Transplantation
  • Tacrolimus

    Product Tacrolimus

    CEP, USDMF, Written confirmation, FDF 
  • Tigecycline

    Product Tigecycline

    EU WC, ASMF

Hangzhou Tomson Biopharma Co., Ltd. Resources (1)